Karyopharm Therapeutics Inc. (KPTI) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-11-13
4:15 pm
Sale
2026-09-3013GKARYOPHARM THERAPEUTICS INC CO
KPTI
Affinity Asset Advisors, LLC1,573,517
6.500%
-500,000decrease
(-24.11%)
Filing
History
2026-11-12
09:06 am
Purchase
2026-09-3013GKARYOPHARM THERAPEUTICS INC CO
KPTI
Adage Capital Management, L.P.2,013,106
8.870%
476,370increase
(+31.00%)
Filing
History
2026-11-09
1:45 pm
Sale
2026-09-3013GKARYOPHARM THERAPEUTICS INC CO
KPTI
THE GOLDMAN SACHS GROUP, INC.
GS
203,129
0.900%
-1,226,069decrease
(-85.79%)
Filing
History
2026-10-28
5:34 pm
Sale
2026-09-3013GKARYOPHARM THERAPEUTICS INC CO
KPTI
Integrated Core Strategies (US) LLC42,888
0.200%
-1,254,409decrease
(-96.69%)
Filing
History
2026-10-08
10:26 am
Sale
2026-10-0213GKARYOPHARM THERAPEUTICS INC CO
KPTI
ACORN BIOVENTURES, L.P.1,021,668
4.500%
-262,553decrease
(-20.44%)
Filing
History
2026-09-25
2:18 pm
Unchanged
2026-09-2213GKARYOPHARM THERAPEUTICS INC CO
KPTI
ACORN BIOVENTURES, L.P.1,284,221
5.700%
0
(Unchanged)
Filing
History
2026-09-25
10:56 am
Sale
2026-09-2213GKARYOPHARM THERAPEUTICS INC CO
KPTI
ACORN BIOVENTURES, L.P.1,284,221
5.700%
-233,892decrease
(-15.41%)
Filing
History
2026-09-04
5:35 pm
Purchase
2026-08-3113GKARYOPHARM THERAPEUTICS INC CO
KPTI
Integrated Core Strategies (US) LLC1,297,297
5.700%
785,726increase
(+153.59%)
Filing
History
2026-08-14
4:44 pm
Purchase
2026-06-3013GKARYOPHARM THERAPEUTICS INC CO
KPTI
RA Capital Management, L.P.2,302,504
9.900%
223,591increase
(+10.76%)
Filing
History
2026-08-14
4:14 pm
Sale
2026-06-3013GKARYOPHARM THERAPEUTICS INC CO
KPTI
Commodore Capital LP0
0.000%
-1,950,000decrease
(Position Closed)
Filing
History
2026-08-12
12:04 pm
Sale
2026-06-3013GKARYOPHARM THERAPEUTICS INC CO
KPTI
Adage Capital Management, L.P.1,536,736
6.780%
-285,000decrease
(-15.64%)
Filing
History
2026-08-11
8:53 pm
Purchase
2026-06-3013GKARYOPHARM THERAPEUTICS INC CO
KPTI
THE GOLDMAN SACHS GROUP, INC.
GS
1,429,198
6.300%
437,834increase
(+44.16%)
Filing
History
2026-07-28
4:44 pm
Purchase
2026-06-3013GKARYOPHARM THERAPEUTICS INC CO
KPTI
BlackRock Inc.
BLK
1,266,084
5.600%
988,098increase
(+355.45%)
Filing
History
2026-06-05
11:43 am
Sale
2026-05-3113GKARYOPHARM THERAPEUTICS INC CO
KPTI
T. Rowe Price Investment Management, Inc.1,539,147
6.600%
-705,274decrease
(-31.42%)
Filing
History
2026-05-15
4:59 pm
Unchanged
2026-03-3113GKARYOPHARM THERAPEUTICS INC CO
KPTI
Ikarian Capital, LLC0
0.000%
0
(Unchanged)
Filing
History
2026-05-15
2:58 pm
Purchase
2026-05-1313GKARYOPHARM THERAPEUTICS INC CO
KPTI
ACORN BIOVENTURES, L.P.1,518,113
6.700%
1,518,113increase
(New Position)
Filing
History
2026-05-14
4:05 pm
Purchase
2026-03-3113GKARYOPHARM THERAPEUTICS INC CO
KPTI
Affinity Asset Advisors, LLC2,073,517
8.600%
360,425increase
(+21.04%)
Filing
History
2026-05-13
09:23 am
Purchase
2026-03-3113GKARYOPHARM THERAPEUTICS INC CO
KPTI
Adage Capital Management, L.P.1,821,736
8.080%
1,385,000increase
(+317.13%)
Filing
History
2026-05-12
3:57 pm
Purchase
2026-03-3113GKARYOPHARM THERAPEUTICS INC CO
KPTI
THE GOLDMAN SACHS GROUP, INC.
GS
991,364
5.100%
991,364increase
(New Position)
Filing
History
2026-05-11
4:23 pm
Sale
2026-03-3113GKARYOPHARM THERAPEUTICS INC CO
KPTI
Opaleye Management Inc.619,089
2.670%
-949,913decrease
(-60.54%)
Filing
History
Goto 0, 1, 2, 3, Next